San Diego

Pulmonary Fibrosis Foundation Names Dr. Franck Rahaghi New President, CEO and Chief Medical Officer

Retrieved on: 
Tuesday, September 5, 2023
San Francisco, Pulmonary fibrosis, Abstract, American College of Chest Physicians, Critical care, Cleveland Clinic, Health policy, University, Education, Internal medicine, Cystic Fibrosis Foundation, ILD, Alternative medicine degrees, Research, Weill Cornell Medical Center, American Thoracic Society, Biomedical engineering, Consultant, Clinical professor, Government, Pulmonology, San Diego, Pulmonary hypertension, MHS, Publication, Biomedicine, MD, Pulmonary Hypertension Association, Berkeley, University of Illinois Urbana-Champaign, FCCP, Rockcastle Regional Hospital and Respiratory Care Center, Nursing care plan, PFF, Health, CCN, Pharmaceutical industry, Nursing, Medicine

CHICAGO , Sept. 5, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) today announced Franck Rahaghi, MD, MHS, FCCP, as its incoming President, Chief Executive Officer and Chief Medical Officer, effective September 15. Following an extensive search, Dr. Rahaghi was selected based on his long-time commitment to care, research, and education in interstitial lung disease (ILD) and pulmonary fibrosis (PF). He will serve in an expanded role as President, CEO and Chief Medical Officer for the PFF.

Key Points: 
  • CHICAGO , Sept. 5, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) today announced Franck Rahaghi, MD, MHS, FCCP, as its incoming President, Chief Executive Officer and Chief Medical Officer, effective September 15.
  • He will serve in an expanded role as President, CEO and Chief Medical Officer for the PFF.
  • In 2003, he joined the medical center as Staff Attending in Pulmonary Critical Care and Director of the Pulmonary Hypertension Clinic.
  • Dr. Rahaghi succeeds Bill Schmidt, former President and CEO of the PFF, and Dr. Joseph Lasky, the Foundation's former Chief Medical Officer.

"TO BOLDLY GO" DOCUMENTARY ANNOUNCES NEW STAR TREK ALUMNI & PASSES 60% FUNDING GOAL ON KICKSTARTER

Retrieved on: 
Wednesday, August 23, 2023
Titan, Curb Your Enthusiasm, Bus, Star Trek: Deep Space Nine, CW, Final, Titan Missile Museum, Marketing, DVD, Valley, History, San Diego, Brandeis-Bardin Institute, Kickstarter, All Good Things, Star Trek, Motion, GalaxyCon, San Diego Comic-Con, Film, Boldly Going Nowhere, The Voyage Home, Star Trek VI: The Undiscovered Country, Star Trek V: The Final Frontier, Blu-ray, Knowledge, LOS, Star Trek IV: The Voyage Home, Academy Awards, Gorn, Film industry, Trek

LOS ANGELES, Aug. 22, 2023 /PRNewswire/ -- The Kickstarter for To Boldly Go, the upcoming documentary spanning 60 years of Hollywood history as told via the filming locations of your favorite Star Trek episodes and movies, has just reached 60% of its goal! The project is the efforts of Writer/Producer Mark A. Altman, creator of The CW's hit docu-series, The Greatest Geek Year Ever: 1982, and bestselling author of Star Trek, The Fifty-Year Mission, and his Inglorious Treksperts co-hosts Daren Dochterman (associate producer, Star Trek: The Motion Picture - Director's Edition), and Ashley E. Miller (screenwriter, Thor, X-Men: First Class).

Key Points: 
  • Part travelogue, part history lesson, part Curb Your Enthusiasm, this epic documentary will feature stars, directors, writers, and producers of multiple Star Trek shows and movies talking about the locations and making of classic episodes throughout the 60-year history of Star Trek.
  • Joining them includes Laurence Luckinbill ("Sybok," Star Trek V: The Final Frontier), Cynthia Gouw ("Caithlin Dar," Star Trek V: The Final Frontier), J.C.
  • With the landing party amassed, expect to see the crew visit legendary locations such as Vasquez Rocks (the scene of the epic Gorn battle in Arena, as well as multiple Star Trek episodes and movies), The Valley of Fire (Star Trek Generations), Bronson Caves (multiple Star Trek episodes and movies), Trona Peaks (Star Trek V), The Titan Missile Museum (Star Trek: First Contact), Calloway Vineyard and Winery ("All Good Things"), Brandeis-Bardin Institute (Star Trek VI), and many more!
    "'
  • Backers have until September 5th to contribute to this unique documentary project by visiting the Kickstarter website at makethetrek.com.

Affirmed Housing Completes New “Missing Middle” and Affordable Housing Development in Downtown San Diego

Retrieved on: 
Tuesday, August 22, 2023
Workforce, Housing, Helm, Nissan MA engine, Head, Helms Bakery, California Housing Finance Agency, San Diego, Walking, City, Restaurant, SAN, Power Plus Pro, AMI, Health, Landscape architecture, Beech Street, Property management, U.S. Bancorp

SAN DIEGO, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Affirmed Housing, a leading developer of affordable housing throughout California, announces the completion of The Helm, a new, mixed-income, affordable housing community for households earning 30 – 80 percent of the area median income (AMI).

Key Points: 
  • SAN DIEGO, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Affirmed Housing, a leading developer of affordable housing throughout California, announces the completion of The Helm, a new, mixed-income, affordable housing community for households earning 30 – 80 percent of the area median income (AMI).
  • ft. of sustainably minded, middle- and low-income workforce housing to Downtown San Diego.
  • “Having an affordable place to call home isn’t about just a roof over your head, it’s the foundation of a thriving community,” said San Diego Mayor Todd Gloria.
  • The 30 percent AMI studios receive project-based vouchers issued by the San Diego Housing Commission.

Startups Converge on The Heritage Group Accelerator to Advance Sustainable Solutions in Hardtech

Retrieved on: 
Monday, August 14, 2023
Cherokee heritage groups, THG, Heritage, Cephalopod, Recycling, Carbon, Aircraft, San Diego, Natural Resources, Risk, Accelerator, Renewable energy

INDIANAPOLIS, Aug. 14, 2023 /PRNewswire-PRWeb/ --The THG Accelerator program provides each startup with hands-on mentorship from seasoned entrepreneurs, scientists, industry professionals, and executives, as well as access to THG's 40+ operating companies for key industry insights and potential pilot opportunities. The program will culminate on November 14, 2023 with its annual HardTech Showcase where the startups will pitch their innovative technologies and business proposals to a global assembly of investors, industry experts, and business leaders.

Key Points: 
  • The Heritage Group (THG) Accelerator is thrilled to announce the selection of nine groundbreaking companies in its 2023 Hardtech Accelerator program at The Heritage Group's cutting-edge innovation hub in Indianapolis.
  • These startups are dedicated to advancing a sustainable future via groundbreaking innovations in the areas of advanced materials, environmental solutions, infrastructure and construction, specialty chemicals, and industrial systems.
  • The THG Accelerator portfolio now encompasses 45 startups, with THG Accelerator alumni having conducted over 30 pilots and raised more than $35 million in follow-on funding in the past four years.
  • For more information about The Heritage Group Accelerator, visit https://hgaccelerator.com/ .

United States Food and Drug Administration (FDA) Authorizes Phase 2 Study of DB107 In Promising Turn-Around of Targeted Treatment to Treat Newly Diagnosed High Grade Glioma

Retrieved on: 
Tuesday, July 25, 2023
Research, FDA, Genetics, Clinical Trials, Health Technology, Biotechnology, Pharmaceutical, Health, Science, Oncology, Partnership, University, UCSD, University of California, SOC, BTRC, USC, Doctor of Philosophy, San Diego, PFS, University of California, San Francisco, RVV, Literature, Patient, UCSF, HGG, Medicine, Vocimagene amiretrorepvec/flucytosine, Analysis of variance, Pharmaceutical industry, Medical imaging, MD

DGM7 has been shown to be associated with increased overall survival with treatment of recurrent HGG, via retrospective analysis.

Key Points: 
  • DGM7 has been shown to be associated with increased overall survival with treatment of recurrent HGG, via retrospective analysis.
  • The Phase 2 study of DB107 will investigate the impact of giving multiple doses of DB107 both directly at time of surgery and intravenously (IV).
  • The study also stratifies patients to more easily identify those individuals who benefit from treatment from those who do not.
  • “By fixing what is broken in clinical research we can conduct better studies and deliver the right treatments to the right patients.”

Sagimet Biosciences Announces Leadership Changes

Retrieved on: 
Thursday, July 20, 2023
Dick Rozek, Intellectual property, Partnership, University, Justice, Therapy, General counsel, NASH, Doctor of Philosophy, United States Department of Justice, Tobacco industry, Acne, MBA, RICO, San Diego, Organization, Santa Clara University, SAN, Corporation, Berkeley, FASN, CFO, Growth, Santa Barbara, Management, DRS

SAN MATEO, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic pathways, today announced a series of leadership changes and appointments, designed to ensure a seamless transition into the next stage of growth for the company.

Key Points: 
  • SAN MATEO, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic pathways, today announced a series of leadership changes and appointments, designed to ensure a seamless transition into the next stage of growth for the company.
  • “It is my privilege to welcome Liz and Tony to the Sagimet leadership team.
  • Ringold and Young for their decade of leadership and support as board members.”
    Tony Rimac joined Sagimet earlier this year as Chief Operating Officer and will serve as Chief Financial Officer beginning in August.
  • He is a seasoned executive with a career spanning three decades of operating and financial leadership, the majority of which was dedicated to the life sciences industry.

Brian Mariotti to Take Leave of Absence and Cease Serving as Funko’s CEO

Retrieved on: 
Thursday, July 13, 2023
Retail, Specialty, Toys, RealNetworks, Partnership, EarthLink, FNKO, Audit committee, San Diego, Lunsford, Love, San Diego Comic-Con, Compensated emancipation, Management, Funko

Funko, Inc. (“Funko”) (Nasdaq: FNKO), a leading pop culture lifestyle brand, announced that Brian Mariotti will take a leave of absence and cease serving as Funko’s CEO with full support from the company’s Board of Directors.

Key Points: 
  • Funko, Inc. (“Funko”) (Nasdaq: FNKO), a leading pop culture lifestyle brand, announced that Brian Mariotti will take a leave of absence and cease serving as Funko’s CEO with full support from the company’s Board of Directors.
  • Effective immediately, the Board of Directors appointed director Michael Lunsford as interim CEO and will also commence a thorough search for a new CEO including internal and external candidates.
  • Mariotti remains a member of the Funko Board of Directors.
  • “Funko has been my labor of love for nearly two decades,” said Mariotti.

New Effort Launches to Bring Professional Women's Soccer to Denver

Retrieved on: 
Tuesday, July 11, 2023
2022 San Diego Wave FC season, U.S. Women's National Team Players Association, National Women's Soccer League, Sixth Street Partners, FC, San Diego, Women's Super League, RSVP, Sports club, NWSL, Super League, City, Football, Nightclub, Sport

DENVER, July 11, 2023 /PRNewswire/ -- For Denver FC, a group of investors and community leaders passionate about women's soccer, announced its intention to bring professional women's soccer to Denver today. Denver supports all five major men's sports, two of them claiming championships in the past 12 months alone. Denver is one of the few major cities in America without a professional women's sports franchise.

Key Points: 
  • DENVER, July 11, 2023 /PRNewswire/ -- For Denver FC, a group of investors and community leaders passionate about women's soccer, announced its intention to bring professional women's soccer to Denver today.
  • Denver is one of the few major cities in America without a professional women's sports franchise.
  • The group is supported by a diverse group of individuals, businesses and investors passionate about bringing professional women's soccer to Colorado.
  • For Denver FC intends to submit a bid to join a Division One professional league by the end of 2023 and bring world class women's soccer to Colorado.

Genius Brands Announces Name Change to 'Kartoon Studios'; Set to Transfer Listing to NYSE American Under New Ticker Symbol, ‘TOON’

Retrieved on: 
Tuesday, June 13, 2023
Mainframe, Sling TV, UNIVERSE, DISH, Bee and PuppyCat, San Diego, LEE, Animation, The Walt Disney Company, San Diego Comic-Con, Prime, Walt Disney, Google Play, STAN, NYSE, Roblox, Television, SONY, Wow Unlimited Media, WOW, Comcast, AMC, Frederator Studios, Marvel, NYSE American, Growth, Tubi, DNA, Apple TV, Pluto TV, IP, Amazon Fire, Amazon, NBA, IOS, Distribution, Genius Brands, LG, StarTimes, Mainframe Studios, Partnership, Ameba TV, Samsung Electronics, Samsung, Bell, Android TV, Channel Frederator Network, CUSIP, Roku, Video game, Film industry, Netflix

BEVERLY HILLS, Calif., June 13, 2023 (GLOBE NEWSWIRE) -- Genius Brands International, Inc. (Genius Brands, (Nasdaq: GNUS) today announced that the Company will be changing its name to Kartoon Studios. In connection with the name change, the Company plans to transfer its listing from the Nasdaq Capital Market (“Nasdaq”) to the NYSE American exchange (“NYSE American”).

Key Points: 
  • (Genius Brands, (Nasdaq: GNUS) today announced that the Company will be changing its name to Kartoon Studios.
  • In connection with the name change, the Company plans to transfer its listing from the Nasdaq Capital Market (“Nasdaq”) to the NYSE American exchange (“NYSE American”).
  • Kartoon Studios is expected to commence trading on the NYSE American exchange when markets open on Monday, June 26, 2023.
  • Effective that date, the Company’s common stock will begin trading under a new trading symbol, “TOON,” and a new CUSIP number, 37229T 509.

The Deerborne Group Projects Strong Growth for Global Next-Generation Sequencing Market

Retrieved on: 
Tuesday, May 30, 2023
NGS, Intelligence, Research, Genomics, COMPASS, San Diego, SAN, Diagnosis, Benchmarking, Disease

SAN DIEGO, May 30, 2023 /PRNewswire/ -- The Deerborne Group, a genomics and precision diagnostics management consultancy, has published a comprehensive assessment of the global market for next-generation sequencing (NGS), including trends and forecasts for 2022–2027.

Key Points: 
  • SAN DIEGO, May 30, 2023 /PRNewswire/ -- The Deerborne Group , a genomics and precision diagnostics management consultancy, has published a comprehensive assessment of the global market for next-generation sequencing (NGS), including trends and forecasts for 2022–2027.
  • The new report estimates the value of the global NGS market in 2022 at $10.9 billion.
  • The market is expected to grow at a 15% CAGR over the forecast period, reaching $21.7 billion in 2027.
  • Report sources were assembled via COMPASS 360° , The Deerborne Group's proprietary process for collecting, analyzing, and interpreting market insights and competitive intelligence.